EFFECT OF MPGES-1 TARGETING ON LIPID METABOLISM IN HUMAN CELLS

被引：0
|
作者：
Korotkova, M. [1 ]
Idborg, H. [1 ]
Raouf, J. [1 ]
Ossipova, E. [1 ]
Checa, A. [2 ]
Olsson, P. [3 ]
Leclerc, P. [1 ]
Oliynyk, G. [1 ]
Wheelock, C. [2 ]
Jakobsson, P. -J. [1 ]
机构：
[1] Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden
[2] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden
[3] Stockholm Univ, Dept Analyt Chem, S-10691 Stockholm, Sweden
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.5002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0078
引用
收藏
页码：829 / 830
页数：2
相关论文
共 50 条
  • [21] The terminal prostaglandin synthases mPGES-1, mPGES-2, and cPGES are all overexpressed in human gliomas
    Mattila, Simo
    Tuominen, Hannu
    Koivukangas, John
    Stenback, Frej
    NEUROPATHOLOGY, 2009, 29 (02) : 156 - 165
  • [22] CHARACTERISATION OF A NEW MPGES-1 INHIBITOR IN HUMAN AND MURINE MODELS OF INFLAMMATION
    Leclerc, Patrick
    Idborg, Helena
    Stenberg, Patrick
    Korotkova, Marina
    Jakobsson, Per-Johan
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : A76 - A76
  • [23] mPGES-1 inhibitors from start to clinic
    Schiffler, Matthew
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [24] Role of neutrophilic mPGES-1 in stroke injury
    Ikeda-Matsuo, Yuri
    Hirayama, Yuri
    Uematsu, Satoshi
    Akira, Shizuo
    Tanabe, Mitsuo
    Sasaki, Yasuharu
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 118 : 149P - 149P
  • [25] Distinction of microsomal prostaglandin E synthase-1 (mPGES-1) inhibition from cyclooxygenase-2 inhibition in cells using a novel, selective mPGES-1 inhibitor
    Mbalaviele, Gabriel
    Pauley, Adele M.
    Shaffer, Alexander F.
    Zweifel, Ben S.
    Mathialagan, Sumathy
    Mnich, Stephen J.
    Nemirovskiy, Olga V.
    Carter, Jeff
    Gierse, James K.
    Wang, Jane L.
    Vazquez, Michael L.
    Moore, William M.
    Masferrer, Jaime L.
    BIOCHEMICAL PHARMACOLOGY, 2010, 79 (10) : 1445 - 1454
  • [26] The Role of mPGES-1 in Inflammatory Brain Diseases
    Ikeda-Matsuo, Yuri
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2017, 40 (05) : 557 - 563
  • [27] mPGES-1: she makes us sick!
    Pecchi, Emilie
    Dallaporta, Michel
    Thirion, Sylvie
    Jean, Andre
    Troadec, Jean Denis
    M S-MEDECINE SCIENCES, 2009, 25 (05): : 451 - 454
  • [28] Is mPGES-1 a promising target for pain therapy?
    Scholich, Klaus
    Geisslinger, Gerd
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2006, 27 (08) : 399 - 401
  • [29] Trisubstituted ureas as potent and selective mPGES-1 inhibitors
    Chiasson, Jean-Francois
    Boulet, Louise
    Brideau, Christine
    Chau, Anh
    Claveau, David
    Cote, Bernard
    Ethier, Diane
    Giroux, Andre
    Guay, Jocelyne
    Guiral, Sebastien
    Mancini, Joseph
    Masse, Frederic
    Methot, Nathalie
    Riendeau, Denis
    Roy, Patrick
    Rubin, Joel
    Xu, Daigen
    Yu, Hongping
    Ducharme, Yves
    Friesen, Richard W.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (05) : 1488 - 1492
  • [30] Identification and development of mPGES-1 inhibitors: where we are at?
    Chang, Hui-Hua
    Meuillet, Emmanuelle J.
    FUTURE MEDICINAL CHEMISTRY, 2011, 3 (15) : 1909 - 1934
12345